ibrutinib,rituximab
abbvie,janssen
[' ibru', 'lymphoma', 'deter,(-determin),(-deterio)']
triangle study in 1l mcl - dreyling ibru with rchop / rdhap &amp; ibr mx + auto superior to chemo / asct alone omission of asct seems non-inf when ibr incorporated in time limited way practise changing study - worthy of #ash22 plenary. 
Associate Professor of Haematology and lymphoma specialist at Oxford Cancer and Haematology centre. Christian, husband and father.